Related Experiment Video
Updated: Aug 17, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted
Alfred E Buxton1, Michael O Sweeney, Mark S Wathen
1Cardiology Division, Department of Medicine, Brown Medical School, Providence, Rhode Island 02905, USA.
Insights
QRS duration and ECG conduction abnormalities do not reliably predict ventricular arrhythmias in coronary artery disease patients with implantable cardioverter-defibrillators. Further prospective studies are needed to clarify the utility of QRS duration for predicting these events.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- QRS duration (QRSd) on ECG correlates with mortality in coronary artery disease (CAD) patients at high risk for sudden death.
- The relationship between QRSd and the risk of ventricular tachyarrhythmias (VT/VF) in CAD patients is not well-defined.
Purpose of the Study:
- To investigate the correlation between QRS duration and the occurrence of ventricular arrhythmias in CAD patients receiving implantable cardioverter-defibrillators (ICDs).
Main Methods:
- Retrospective analysis of the PainFREE Rx II trial data.
- Correlated QRS duration and ECG conduction abnormalities with VT/VF occurrence in 431 CAD patients with ICDs.
Main Results:
- No significant difference in VT/VF occurrence was observed between patients with QRSd ≤120 ms and those with QRSd >120 ms (22% vs. 23%, p=NS).
- Left bundle branch block (LBBB) was associated with a lower likelihood of VT/VF compared to QRSd <120 ms.
- Right bundle branch block (RBBB) and non-specific intraventricular conduction delay (IVCD) did not show a different risk for tachyarrhythmias compared to narrow QRS complexes.
Conclusions:
- QRS duration and ECG conduction abnormalities are not effective predictors of ICD benefit in this patient population.
- Further prospective evaluation is required to determine the utility of QRS duration in predicting VT/VF events in CAD patients.
Objectives:
The aim of this study was to determine whether QRS duration (QRSd) correlates with occurrence of ventricular arrhythmia in patients with coronary disease (CAD) receiving implantable cardioverter-defibrillators (ICDs).
Background:
A QRSd measured on a standard electrocardiograph (ECG) correlates with total mortality risk in CAD patients at high risk for sudden death; however, the relationship between QRSd and risk of ventricular tachyarrhythmias (ventricular tachycardia/ventricular fibrillation [VT/VF]) is unclear.
Methods:
PainFREE Rx II was a randomized trial, comparing efficacy of antitachycardia pacing versus shock therapy for VT/VF in patients receiving ICDs. We retrospectively correlated the QRSd and specific ECG conduction abnormalities on the 12-lead ECG at study entry with occurrence of VT/VF in 431 patients with CAD enrolled in the trial.
Results:
The QRSd was < or =120 ms in 291 of 431 (68%) patients. Left bundle branch block (LBBB) was present in 65 patients, right bundle branch block (RBBB) in 48 patients, and nonspecific intraventricular conduction delay (IVCD) was present in 124 patients. Over 12 months' follow-up, VT/VF occurred in 95 (22%) patients (22% of patients with QRSd < or =120 ms vs. 23% of patients with QRSd >120 ms, p = NS). Patients with LBBB were less likely to experience at least one VT/VF episode than patients with QRSd <120 ms. Patients with RBBB and nonspecific IVCD did not differ from patients with narrow QRS complexes with regard to occurrence of tachycardias.
Conclusions:
The QRSd and ECG conduction abnormalities are not useful to predict ICD benefit in patients having the characteristics of our study population. The utility of QRSd to predict VT/VF events in patients with CAD requires further prospective evaluation.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
